Publications GLP-1 Analog Use is Associated With Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN Gorelik Y, Ghersin I, Lujan R, Shlon D, Loewenberg Weisband Y, Ben-Tov A, Matz E, Zacay G, Dotan I, Turner D, Bar-Yoseph H. J Crohns Colitis. 2025 Apr 4;19(4):jjae160. doi: 10.1093/ecco-jcc/jjae160.PMID: 39441993 The Future of Microbiome Therapeutics Pitashny M, Kesten I, Shlon D, Hur DB, Bar-Yoseph H. Drugs. 2025 Feb;85(2):117-125. doi: 10.1007/s40265-024-02107-3. Epub 2025 Jan 23.PMID: 39843757 Bile acid-induced metabolic changes in the colon promote Enterobacteriaceae expansion and associate with dysbiosis in Crohn's disease Holani R*, Bar-Yoseph H*, Krekhno Z, Serapio-Palacios A, Moon KM, Stacey RG, Donald KA, Deng W, Bressler B, Magaña AA, Foster LJ, Atser MG, Johnson JD, Finlay B. Sci Signal. 2024 Dec 17;17(867):eadl1786. doi: 10.1126/scisignal.adl1786. Epub 2024 Dec 17.PMID: 39689182 *First shared co-author Fecal microbiota transplantation: current challenges and future landscapes Yadegar A, Bar-Yoseph H, Monaghan TM, Pakpour S, Severino A, Kuijper EJ, Smits WK, Terveer EM, Neupane S, Nabavi-Rad A, Sadeghi J, Cammarota G, Ianiro G, Nap-Hill E, Leung D, Wong K, Kao D. Clin Microbiol Rev. 2024 Jun 13;37(2):e0006022. doi: 10.1128/cmr.00060-22. Epub 2024 May 8.PMID: 38717124 Microbiome changes under enteral deprivation are dynamic and dependent on intestinal location Bar-Yoseph H, Metcalfe-Roach A, Cirstea M, Finlay BB. JPEN J Parenter Enteral Nutr. 2024 May;48(4):502-511. doi: 10.1002/jpen.2624. Epub 2024 Mar 24.PMID: 38522020 The Effect of Nutrient Deprivation on Early Life Small Intestinal Mucosal Microbiome and Host Proteome Bar-Yoseph H, Krekhno Z, Cirstea M, Holani R, Moon KM, Foster LJ, Wieck M, Piper HG, Finlay BB. J Nutr. 2024 Feb;154(2):412-423. doi: 10.1016/j.tjnut.2023.12.020. Epub 2023 Dec 16.PMID: 38110179 The Association Between Low Body-Mass Index and Serious Post-endoscopic Adverse Events Glaubach N, Ben Hur D, Korytny A, Isenberg Y, Laham Y, Almog R, Chermesh I, Weisshof R, Bar-Yoseph H. Dig Dis Sci. 2023 Jun;68(6):2180-2187. doi: 10.1007/s10620-023-07882-9. Epub 2023 Mar 8.PMID: 36884185 Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients Bar-Yoseph H, Blatt A, Gerassy S, Pressman S, Mousa A, Sabo E, Waterman M, Ungar B, Ben-Horin S, Chowers Y. J Crohns Colitis. 2022 Jul 14;16(6):884-892. doi: 10.1093/ecco-jcc/jjab208.PMID: 34849649 Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure Daoud-Asfour H, Henig I, Ghersin I, Rakedzon S, Stern A, Pitashny M, Zuckerman T, Bar-Yoseph H. Transplant Cell Ther. 2022 Mar;28(3):168.e1-168.e8. doi: 10.1016/j.jtct.2021.12.012. Epub 2021 Dec 23.PMID: 34954293 Risk Factors for Bacteremia After Endoscopic Procedures in Hospitalized Patients With a Focus on Neutropenia Isenberg Y, Zamstein N, Horesh N, Chowers Y, Bar-Yoseph H. J Clin Gastroenterol. 2022 Jan 1;56(1):e58-e63. doi: 10.1097/MCG.0000000000001476.PMID: 33337641 Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective Bar-Yoseph H, Carasso S, Shklar S, Korytny A, Even Dar R, Daoud H, Nassar R, Maharshak N, Hussein K, Geffen Y, Chowers Y, Geva-Zatorsky N, Paul M. Clin Infect Dis. 2021 Jul 1;73(1):e166-e175. doi: 10.1093/cid/ciaa737.PMID: 32511695 Does early corticosteroid therapy affect prognosis in IBD patients hospitalized with Clostridioides difficile infection? Bar-Yoseph H, Daoud H, Ben Hur D, Chowers Y, Waterman M.Int J Colorectal Dis. 2020 Mar;35(3):513-519. doi: 10.1007/s00384-019-03502-z. Epub 2020 Jan 11.PMID: 31927638 Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies Bar-Yoseph H, Pressman S, Blatt A, Gerassy Vainberg S, Maimon N, Starosvetsky E, Ungar B, Ben-Horin S, Shen-Orr SS, Chowers Y; Israeli IBD Research Nucleus. Gastroenterology. 2019 Nov;157(5):1338-1351.e8. doi: 10.1053/j.gastro.2019.08.009. Epub 2019 Aug 8.PMID: 31401142 Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines Bar-Yoseph H, Waterman M, Almog R, Billiet T, Vermeire S, Ungar B, Yanai H, Dotan I, Ben-Horin S, Chowers Y. Clin Gastroenterol Hepatol. 2017 Jan;15(1):69-75. doi: 10.1016/j.cgh.2016.06.028. Epub 2016 Jul 9.PMID: 27404966 Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis Bar-Yoseph H, Hussein K, Braun E, Paul M. J Antimicrob Chemother. 2016 Oct;71(10):2729-39. doi: 10.1093/jac/dkw221. Epub 2016 Jun 17.PMID: 27317444 A comprehensive list of publications is available: https://www.ncbi.nlm.nih.gov/myncbi/18Q3hCK14RG5P/bibliography/public/